About electroCore Company
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
GammaCore Non-Invasive Vagus Nerve Stimulation (NVNS) Improves Attention and Working Memory in Patients With Post Traumatic Stress Disorder (PTSD)
ROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of two peer reviewed publications supporting the use of gammaCore (non-invasive vagal nerve stimulation; nVNS) in patients with posttraumatic stress disorder (PTSD).
ElectroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (NVNS) Technology
ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trad
IAccess Alpha Best Ideas From the Buyside Virtual Conference - Sep 26th-27th 2023
RALEIGH, NC / ACCESSWIRE / September 25, 2023 / iAccess Alpha's Top 10 Best Ideas from the buyside virtual conference is taking place September 26th & 27th, 2023.The conference begins on Tuesday, Sept